• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全肺切除术:非小细胞肺癌的适应证及治疗结果

Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer.

作者信息

Yazgan Serkan, Üçvet Ahmet, Gürsoy Soner, Samancılar Özgür

机构信息

Department of Thoracic Surgery, University of Health Sciences, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Sep 16;26(4):626-635. doi: 10.5606/tgkdc.dergisi.2018.16159. eCollection 2018 Oct.

DOI:10.5606/tgkdc.dergisi.2018.16159
PMID:32082806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7018186/
Abstract

BACKGROUND

This retrospective single-center study aims to review the indications and outcomes of completion pneumonectomy after primary resection due to non-small cell lung cancer.

METHODS

Of a total of 452 patients who underwent pneumonectomy between January 2004 and August 2017 for non-small cell lung cancer, 29 (24 males, 5 females; mean age 59.9±7.1 years; range, 45 to 72 years) were performed completion pneumonectomy. Patients" indications, factors affecting early and late-term outcomes, operative mortality and survival rates were analyzed.

RESULTS

Operative mortality rate was 24.1%, including two intraoperative and five postoperative deaths. Complication rate was 44.8% and the most frequent complication was bronchopleural fistula with 24.1%. Study population was divided into two groups. While elective completion pneumonectomy group (n=19) consisted of recurrent malignant tumor patients, rescue completion pneumonectomy group (n=10) consisted of patients performed urgent pneumonectomy due to a bronchopulmonary complication developing after an anatomic lung resection. The morbidity and mortality rates for elective completion pneumonectomy and rescue completion pneumonectomy were 26.3% and 21.1%; and 70% and 30%, respectively. The morbidity for rescue completion pneumonectomy was significantly higher than elective completion pneumonectomy (p=0.016). Advanced age and presence of any preoperative risk (comorbidity and neoadjuvant treatment) were related to higher operative mortality (p=0.019 and p=0.049, respectively). The median survival after completion pneumonectomy was 19.5 months (95% confidence interval 17.2 to 21.9 months).

CONCLUSION

The morbidity and mortality rates of completion pneumonectomy are higher than standard pneumonectomy. Rescue completion pneumonectomy is related to higher postoperative risk, but has better survival. The most significant complication after completion pneumonectomy is bronchopleural fistula. Advanced age and presence of any preoperative risk are related to statistically significantly higher mortality in completion pneumonectomy. Nevertheless, completion pneumonectomy is still a significant treatment option in selected patients.

摘要

背景

本回顾性单中心研究旨在回顾因非小细胞肺癌初次切除术后行全肺切除术的适应证及治疗结果。

方法

在2004年1月至2017年8月期间,共有452例因非小细胞肺癌接受肺切除术的患者,其中29例(24例男性,5例女性;平均年龄59.9±7.1岁;范围45至72岁)接受了全肺切除术。分析了患者的适应证、影响早期和晚期结果的因素、手术死亡率和生存率。

结果

手术死亡率为24.1%,包括2例术中死亡和5例术后死亡。并发症发生率为44.8%,最常见的并发症是支气管胸膜瘘,发生率为24.1%。研究人群分为两组。选择性全肺切除术组(n = 19)由复发性恶性肿瘤患者组成,挽救性全肺切除术组(n = 10)由因解剖性肺切除术后发生支气管肺并发症而进行紧急肺切除术的患者组成。选择性全肺切除术和挽救性全肺切除术的发病率和死亡率分别为26.3%和21.1%;以及70%和30%。挽救性全肺切除术的发病率明显高于选择性全肺切除术(p = 0.016)。高龄和任何术前风险(合并症和新辅助治疗)与较高的手术死亡率相关(分别为p = 0.019和p = 0.049)。全肺切除术后的中位生存期为19.5个月(95%置信区间17.2至21.9个月)。

结论

全肺切除术的发病率和死亡率高于标准肺切除术。挽救性全肺切除术与较高的术后风险相关,但生存率较好。全肺切除术后最显著的并发症是支气管胸膜瘘。高龄和任何术前风险与全肺切除术中统计学上显著较高的死亡率相关。然而,全肺切除术仍然是特定患者的重要治疗选择。

相似文献

1
Completion pneumonectomy: Indications and outcomes in non-small cell lung cancer.全肺切除术:非小细胞肺癌的适应证及治疗结果
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Sep 16;26(4):626-635. doi: 10.5606/tgkdc.dergisi.2018.16159. eCollection 2018 Oct.
2
Completion pneumonectomy is safe and effective in select patients with recurrent non-small cell lung cancer.对于部分复发性非小细胞肺癌患者,全肺切除术是安全有效的。
J Thorac Dis. 2020 Mar;12(3):217-222. doi: 10.21037/jtd.2020.01.51.
3
Factors affecting early and long-term outcomes after completion pneumonectomy.全肺切除术后影响早期和长期预后的因素。
Eur J Cardiothorac Surg. 2008 May;33(5):837-43. doi: 10.1016/j.ejcts.2008.02.006. Epub 2008 Mar 14.
4
[Clinical analysis of completion pneumonectomy for pulmonary disease].[肺疾病全肺切除术的临床分析]
Zhonghua Wai Ke Za Zhi. 2007 Aug 15;45(16):1132-5.
5
Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity.全肺切除术:影响手术死亡率和心肺并发症的因素
Ann Thorac Surg. 2002 Sep;74(3):876-83; discussion 883-4. doi: 10.1016/s0003-4975(02)03855-9.
6
[Completion pneumonectomy: indications, complications, and results].[全肺切除术:适应症、并发症及结果]
Tuberk Toraks. 2004;52(1):56-62.
7
Completion pneumonectomy in cancer patients: experience with 55 cases.癌症患者的全肺切除术:55例经验
Eur J Cardiothorac Surg. 2004 Mar;25(3):449-55. doi: 10.1016/j.ejcts.2003.12.002.
8
Neoadjuvant chemotherapy is a risk factor for bronchopleural fistula after pneumonectomy for non-small cell lung cancer.新辅助化疗是非小细胞肺癌肺切除术后发生支气管胸膜瘘的一个危险因素。
Kardiochir Torakochirurgia Pol. 2014 Mar;11(1):40-3. doi: 10.5114/kitp.2014.41929. Epub 2014 Mar 27.
9
Completion pneumonectomy: analysis of operative mortality and survival.全肺切除术:手术死亡率及生存率分析
Ann Thorac Surg. 1998 Oct;66(4):1165-9. doi: 10.1016/s0003-4975(98)00599-2.
10
Completion pneumonectomy: a valuable option for lung cancer recurrence or new primaries.全肺切除术:肺癌复发或新原发肿瘤的有价值选择。
World J Surg Oncol. 2018 May 28;16(1):98. doi: 10.1186/s12957-018-1398-2.

本文引用的文献

1
Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC).立体定向体部放射治疗(SBRT)用于复发性非小细胞肺癌(NSCLC)。
Anticancer Res. 2016 Feb;36(2):825-8.
2
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.IASLC 肺癌分期项目:对即将发布的(第八版)肺癌 TNM 分类中 TNM 分期分组的修订建议。
J Thorac Oncol. 2016 Jan;11(1):39-51. doi: 10.1016/j.jtho.2015.09.009.
3
Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer.全肺切除术及放化疗作为非小细胞肺癌局部复发的治疗选择。
Kardiochir Torakochirurgia Pol. 2015 Mar;12(1):18-25. doi: 10.5114/kitp.2015.50563. Epub 2015 Mar 31.
4
The early and long-term outcomes of completion pneumonectomy: report of 56 cases.全肺切除术的早期及长期疗效:56例报告
Interact Cardiovasc Thorac Surg. 2014 Sep;19(3):436-40. doi: 10.1093/icvts/ivu125. Epub 2014 Jun 3.
5
Completion pneumonectomy: outcomes for benign and malignant indications.全肺切除术:良性和恶性适应证的结果。
Ann Thorac Surg. 2013 Jun;95(6):1885-90; discussion 1890-1. doi: 10.1016/j.athoracsur.2013.04.014. Epub 2013 May 3.
6
Completion pneumonectomy for lung cancer treatment: early and long term outcomes.全肺切除术治疗肺癌:早期和长期疗效
J Cardiothorac Surg. 2012 Oct 9;7:107. doi: 10.1186/1749-8090-7-107.
7
Completion pneumonectomy in patients with cancer: postoperative survival and mortality factors.癌症患者全肺切除术:术后生存和死亡因素。
J Thorac Oncol. 2012 Oct;7(10):1556-62. doi: 10.1097/JTO.0b013e31826419d2.
8
Completion pneumonectomy: a multicentre international study on 165 patients.全肺切除术:165 例患者的多中心国际研究。
Eur J Cardiothorac Surg. 2012 Sep;42(3):405-9. doi: 10.1093/ejcts/ezs063. Epub 2012 Mar 6.
9
Factors affecting early and long-term outcomes after completion pneumonectomy.全肺切除术后影响早期和长期预后的因素。
Eur J Cardiothorac Surg. 2008 May;33(5):837-43. doi: 10.1016/j.ejcts.2008.02.006. Epub 2008 Mar 14.
10
Completion pneumonectomy for chronic mycobacterial disease.慢性分枝杆菌病的全肺切除术
J Thorac Cardiovasc Surg. 2005 Jun;129(6):1258-65. doi: 10.1016/j.jtcvs.2004.12.053.